Lee Frank D.
Director at BHC; President and CEO at Forma Therapeutics Holdings, Inc.,
- Sold, on record
- $431k
- Dollars the filings state
- Form 4 sales
- 3
- Latest May 19, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- BHCBausch Health Companies Inc.Director
- Forma Therapeutics Holdings, Inc.,President and CEO
Sales by reason
1
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- BHC40,368 shares
- Forma Therapeutics Holdings, Inc.,17,981 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Forma Therapeutics Holdings, Inc.,Plan not statedFeb 23, 2022 2022
Sold 17,981 shares at $9.78 ($176k)
Lee Frank D., President and CEO
Sold 18.4% of holdings ($956k position)79,769 shares leftFirst sale on recordFiling
- 2 Form 4 sale BHCNo planAug 21, 2025 +1275 days
Sold 15,912 shares at $7.66 ($122k)
Lee Frank D., Director
No 10b5-1 planSold 17.7% of holdings ($687k position)73,795 shares leftFirst sale on recordFiling
- 3 Form 4 sale BHCRoutineMay 19, 2026 +271 days
Sold 24,456 shares at $5.43 ($133k)
Lee Frank D., Director
10b5-1 planSold 33.1% of holdings ($401k position)49,339 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2026 | May 20, 2026 | BHC | Director | Form 4 sale | 24,456 | $133k | 33.1% | Routine | SEC |
| Aug 21, 2025 | Aug 22, 2025 | BHC | Director | Form 4 sale | 15,912 | $122k | 17.7% | No plan | SEC |
| Feb 23, 2022 | Feb 25, 2022 | Forma Therapeutics Holdings, Inc., | President and CEO | Form 4 sale | 17,981 | $176k | 18.4% | Plan not stated | SEC |